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Objectives To explore and compare the knowledge, 
attitudes and experiences of doctors, dentists and 
veterinarians (as prescribers) in relation to antibiotic 
use and antibiotic resistance (AbR), and to consider the 
implications of these for policy-making that support a One 
Health approach.
Design A cross-sectional survey conducted online.
setting Doctors, dentists and veterinarians practising in 
primary, secondary or tertiary care in Australia.
Participants 547 doctors, 380 dentists and 403 
veterinarians completed the survey.
Main outcome measures Prescribers’ knowledge, 
attitudes and perceptions of AbR, the extent to which a 
range of factors are perceived as barriers to appropriate 
prescribing practices, and perceived helpfulness of 
potential strategies to improve antibiotic prescribing in 
practice.
results There was substantial agreement across 
prescriber groups that action on AbR is required by 
multiple sectors and stakeholders. However, prescribers 
externalised responsibility to some extent by seeing the 
roles of others as more important than their own in relation 
to AbR. There were common and context-specific barriers 
to optimal prescribing across the prescriber groups. 
Prescriber groups generally perceived restrictive policies 
as unhelpful to supporting appropriate prescribing in their 
practice.
Conclusions The results have implications for 
implementing a One Health approach that involves doctors, 
dentists and veterinarians as key players to tackling 
the crisis of AbR. The findings are that (1) prescribers 
understand and are likely receptive to a One Health policy 
approach to AbR, (2) policy development should be sensitive 
to barriers that are specific to individual prescriber groups 
and (3) the development and introduction of interventions 
that might be perceived as reducing prescriber autonomy 
will need to be carefully designed and implemented.
IntrODuCtIOn 
Antimicrobial resistance (AMR) is 
recognised as a complex problem and 
global threat to human and animal health.1 
Consequently, the WHO and its member 
states advocate a One Health approach to 
tackle the crisis of AMR.2 3 One Health 
recognises that the health of humans, 
animals and the environment is interlinked 
such that collaborative, multidisciplinary 
efforts of researchers, policy-makers, 
strengths and limitations of this study
 ► The simultaneous surveying of doctors, dentists 
and veterinarians allowed for direct comparisons 
between knowledge, attitudes and perceptions to 
reveal the gaps, opportunities and challenges for a 
One Health approach towards appropriate the use of 
antibiotics—a global first.
 ► The development of the questionnaires was un-
dertaken in partnership with the key national pol-
icy-making authority in the Department of Health 
ensuring relevancy.
 ► The sample size is modest. However, respondent 
characteristics were broadly comparable with na-
tional workforce statistics, representing a range of 
practice types and locations, years of experience, 
age and gender. Some groups in some Australian 
states were under-represented in the sample.
 ► The self-selected approach to participant re-
cruitment could have led to selection bias of 
individuals who were already interested in or knowl-
edgeable about the topic of antibiotic resistance and 
stewardship.
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practitioners and other stakeholders will be required 
locally, nationally and globally to achieve an effective 
response.4 Due to the complexity of AMR, those tasked 
with the responsibility of policy-making (which here 
includes the development of regulations, guidelines, 
plans, strategies and interventions) require a deeper 
understanding of the key drivers across the supply and 
demand sides of antimicrobial use.5 
A cornerstone of the One Health approach to 
AMR and a key priority of the WHO AMR response 
strategy is to reduce misuse of antimicrobials and 
support optimal prescribing practices in human and 
animal health.2 3 The effectiveness of strategies that 
aim to improve prescribing practices depend, in part, 
on the extent to which factors affecting suboptimal 
prescribing, barriers to change and prescriber atti-
tudes to potential interventions are understood and 
addressed.6 With this in mind, policies will need to 
be sensitive to the commonalities and differences 
between prescriber groups. A complex set of factors 
influence antimicrobial prescribing behaviour among 
doctors, dentists and veterinarians. These include the 
availability and acceptance of guidelines and other 
information sources; level of knowledge and training; 
perceptions about the causes, impacts and risks of 
AMR; availability of diagnostic facilities and diag-
nostic uncertainty; pressure from patients/clients; 
fear of clinical failure; time pressures and social and 
organisational contexts.7–12
Empirical research is needed to support targeted, 
effective policies to change prescribing practices. To 
date, investigation of knowledge, attitudes, percep-
tions and behaviours among practitioners has generally 
involved single professions only. This limits the range 
and comparability of information needed to support 
the development of policies that target multiple 
prescriber groups.13 In addition, no surveys have 
compared prescribers’ understanding of the intercon-
nected nature of AMR across human, animal and envi-
ronmental sectors. Given that One Health is central to 
international and national efforts to manage AMR, the 
response of prescribers to this new approach has impli-
cations for whether it will be accepted. To address these 
gaps, concurrent surveys were undertaken of three key 
prescriber groups in Australia: doctors, dentists and 
veterinarians. The aims were to: (1) identify common-
alities and differences between prescribers’ knowl-
edge, attitudes and perceptions of AMR, factors and 
barriers influencing prescribing and perceptions of 
possible intervention strategies to improve antibiotic 
prescribing and (2) consider the implications of the 
findings for policy-making that support a One Health 
approach. For the purpose of this study, antibiotic 
resistance (AbR) is the focus rather than AMR, because 
antibiotics are the most commonly prescribed antimi-
crobials. This study uses the WHO definition of ‘antibi-




Self-administered surveys targeted doctors, dentists and 
veterinarians in Australia, canvassing information on 
demographics, practice characteristics, knowledge, atti-
tudes and beliefs about antibiotic use and effectiveness, 
barriers influencing prescribing, and attitudes towards 
possible interventions. Demographic and practice-related 
questions were profession-specific. Otherwise questions 
were identical.
Survey questions were designed in collaboration with 
experienced doctors, dentists and veterinarians, who also 
assisted with data analysis (see coauthors). Some ques-
tion items were adapted from existing studies targeting 
doctors15–17 and veterinarians,18 19 and qualitative studies 
exploring knowledge and perceptions among doctors,20 
dentists8 21 and veterinarians.9 Feedback was received 
from the Office of Health Protection, The Department 
of Health, Australian Government, who are coleading 
Australia’s AMR strategy 2015−2019 and implementa-
tion plan, to ensure that the data generated were rele-
vant to national policy development.3 Most questions 
were closed-ended with Likert-type responses measured 
on 4-point or 5-point scale. ‘Unsure’, ‘neutral’ and ‘not 
applicable (N/A)’ options were also provided where 
appropriate. The questionnaire was pretested in all three 
professions and feedback was used to guide the final 
design.
recruitment and data collection
Surveys were hosted on SurveyMonkey and distributed 
online between October and December 2016. Respon-
dents were reached via researchers’ networks, profes-
sional associations, professional colleges and practitioner 
registers through their newsletters, bulletins, email lists, 
forum announcements and websites (see online supple-
mentary material). For dentists, a marketing mailing list 
was also used.
Data and statistical analyses
Statistical analyses were conducted using IBM SPSS Statis-
tics V.22. Respondents completing the demographic 
questions and at least one other question was included 
in the analyses. In cases of missing data on a single item, 
the respondent was excluded from the respective analysis 
(listwise deletion). Medians and IQRs were calculated 
and reported for questions with an ordinal response 
scale. Kruskal-Wallis H statistical tests were conducted to 
determine whether there were significant (p<0.05) differ-
ences in median responses and mean ranks between 
doctors, dentists and/or veterinarians (referred to in the 
notes at the bottom of figures 1–3, respectively); post hoc 
analyses of pairwise comparisons were performed using 
Dunn’s (1964) procedure, with a Bonferroni correc-
tion for multiple comparisons, to estimate adjusted p 
values.22‘N/A’ and ‘Unsure’ responses were excluded 
from all statistical analyses.




Overall, 1549 professionals responded to the survey. 
However, 219 were excluded because their responses to 
demographic questions were incomplete, leaving 1330 
responses comprising 547 doctors, 380 dentists and 403 
veterinarians, representing 0.6%, 2.3% and 3.9%, respec-
tively, of each national workforce (table 1). Respondents 
were broadly comparable to the characteristics of the 
national workforce of the three prescriber groups across 
Australian states and territories although there were 
some anomalies (eg, Victoria doctors were under-repre-
sented, Western Australia dentists were over-represented 
and Queensland veterinarians were under-represented 
(table 1)).
For doctors and dentists, about equal numbers of women 
and men responded. Among veterinarians, women were 
over-represented (table 1). Respondent age profiles in all 
three profession samples were broadly consistent with the 
national age profile of each profession.
Figure 1 (A,B) Respondents’ knowledge and perceptions of antibiotic effectiveness and causes of AbR. (A) Knowledge and 
beliefs about AbR and (B) perceptions of factors contributing to the issue of AbR. AbR, antibiotic resistance.
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Half of the doctors (52.8%) and a majority of dentists 
(62.4%) and veterinarians (77.2%; mostly small 
companion animal 66.5%) were in private practice 
(table 2). Among doctors, the proportion of respon-
dents that worked in each particular setting (eg, private 
practice and hospital) was comparable with national 
workforce data (table 2). Dentists working in publicly 
funded services were over-represented and veterinar-
ians working in mixed practices were under-repre-
sented (table 2).
Figure 2 (A–C) Respondents’ perceptions of drivers, extent of the problem and importance of stakeholders in the issue 
of AbR. (A) Beliefs about current levels of antibiotic use as drivers of AbR, (B) perceived extent of the AbR problem and (C) 
perceived importance of stakeholders in managing/preventing the issue of AbR. AbR, antibiotic resistance.
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Knowledge and perceptions about Abr
The following results report on the median response 
categories (in quotation marks) of each prescriber 
group. Results of the statistical tests, and commonalities 
and statistically significant differences (p<0.05) between 
prescriber groups’ responses are shown in figures 1–3. 
See online supplementary material for complete data 
tables.
There were similarities and differences between 
doctors, dentists and veterinarians with respect to their 
levels of knowledge and awareness of AbR (figure 1A). 
Dentists were less likely than doctors and veterinarians to 
agree that a single course of antibiotics can cause AbR 
(figure 1A). Doctors were more likely than dentists and 
veterinarians to agree that AbR bacteria may last a year 
in a patient after a single use of an antibiotic (figure 1A).
Each prescriber group generally regarded too many 
antibiotic prescriptions and prescribing for minor or 
self-limiting illnesses as ‘significant’ contributors to AbR 
(figure 1B). There were some differences: veterinar-
ians were less likely than others to rate unnecessary use 
of broad-spectrum agents, prescribing with uncertain 
Figure 3 (A–C) Factors influencing prescribing decisions and perceptions of strategies to improve antibiotic prescribing. (A) 
Factors influencing decisions whether or not to prescribe antibiotics, (B) barriers to prescribing antibiotics appropriately and (C) 
perceived helpfulness of measures aimed at supporting appropriate prescribing of antibiotics.
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benefit and longer antibiotic courses as ‘significant’, but 
more likely to rate low doses of antibiotics as ‘signifi-
cant’ contributors to ABR; dentists were more likely than 
others to rate failure to remove the source of infection 
as ‘significant’; and doctors were less likely than others 
to consider patients not taking a full course or using left-
over antibiotics as ‘significant’ (figure 1B). All groups 
rated transfer of resistant bacteria between humans, 
animals and environment, environmental contamination 
with antibiotic waste and hygiene as ‘moderate’ contribu-
tors (figure 1B).
Each group rated current levels of unregulated use of 
antibiotics globally and antibiotic use in human hospitals, 
as making ‘significant’ contributions to AbR (figure 2A). 
Dentists rated current levels of antibiotic use in nursing 
homes/aged care facilities and in general medical 

















n % N % n % N % n % N %
States/territories
  NSW 163 29.8 28 144 32.0 72 18.9 5145 31.6 111 27.5 2735 26.8
  VIC 82 15.0 21 918 24.9 32 8.4 3829 23.5 83 20.6 2573 25.2
  QLD 114 20.8 17 551 19.9 111 29.2 3238 19.9 37 9.2 2434 23.8
  SA 55 10.1 6713 7.6 6 1.6 1168 7.2 10 2.5 616 6.0
  WA 46 8.4 8952 10.2 131 34.5 1749 10.7 93 23.1 1258 12.3
  TAS 20 3.7 1900 2.2 9 2.4 231 1.4 32 7.9 219 2.1
  NT 14 2.6 1102 1.3 8 2.1 105 0.6 4 1.0 121 1.2
  ACT 49 9.0 1715 1.9 11 2.9 293 1.8 31 7.7 251 2.5
  Missing 4 0.7 45 0.1 0 0.0 547 3.4 2 0.5 0 0.0
  Total 547 100.0 88 040 100.0 380 100.0 16 305 100.0 403 100.0 10 207 100.0
Gender
  Female 284 51.9 35 282 40.1 183 48.0 5452 39.0 261 64.9 5513 55.9
  Male 263 48.1 52 758 59.9 197 52.0 8527 61.0 141 35.1 4346 44.1
  Valid total 547 100.0 88 040 100.0 380 100.0 13 979 100.0 402 100.0 9860 100.0
  Missing 0 0 0 0 1 0
Age (years)
  <35 149 27.7 20 344 23.1 112 29.9 4462 33.7 139 34.9 3512 35.6
  35–54 227 42.3 43 774 49.7 152 40.4 5935 44.8 179 45.0 4684 47.5
  >55 161 30.0 23 922 27.2 111 29.7 2846 21.5 80 20.1 1663 16.9
  Valid total 537 100.0 88 040 100.0 375 100.0 13 243 100.0 398 100.0 9859 100.0
  Missing 10 0 5 0 5 1
Years of experience
  <10 169 30.9 nd nd 117 30.9 nd nd 134 33.3 nd nd
  10–19 130 23.8 nd nd 84 22.2 nd nd 109 27.0 nd nd
  20–29 84 15.4 nd nd 60 15.8 nd nd 66 16.4 nd nd
  >30 163 29.9 nd nd 118 31.1 nd nd 94 23.3 nd nd
  Valid total 546 100.0 nd nd 379 100.0 nd nd 403 100.0 nd nd
  Missing 1 1 0
*National medical workforce data from AIHW.42
†National dentist workforce state/territory data from Dental Board of Australia.43 Gender and age data from AIHW.44
‡National veterinarian workforce data from AVA.45
ACT, Australian Capital Territory; AIHW, Australian Institute of Health and Welfare; AVA, Australian Veterinary Association; QLD, Queensland; 
nd, no data available; NSW, New South Wales; NT, Northern Territory; SA, South Australia; TAS, Tasmania; VIC, Victoria; WA, Western 
Australia. 
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Table 2 Respondents’ fields of work and practice types
Survey respondents National workforce
n % N %
Medical respondents*
  Main field
   GP 266 48.6 28 329 32.2
   Specialist 128 23.4 31 189 35.4
   Specialist-in-training 88 16.1 15 336 17.4
   Hospital non-specialist 65 11.9 9880 11.2
   Other clinician/non-clinician 0 0.0 3306 3.8
   Total 547 100.0 88 040 100.0
  Main work setting
   Private practice 289 52.8 41 902 47.6
   Hospital practice 225 41.1 38 235 43.4
   Educational facility 10 1.8 1876 2.1
   Other 23 4.2 6027 6.9
   Total 547 100.0 88 040 100.0
Dental respondents†
  Main field
   General dentist 336 88.4 14 635 89.8
   Specialist dentist 44‡ 11.6‡ 1670§ 10.2§
   Total 380 100.0 16 305 100.0
  Main work setting
   Private practice 237 62.4 10 320 77.8
   Publicly funded services (public hospital, community 
healthcare clinic, Aboriginal health service and defence force)
119 31.3 1514 11.4
   Educational facility (university) 24 6.3 282 2.1
   Other/not stated 0 0.0 1150 8.7
   Total 380 100.0 13 266 100.0
Veterinary respondents¶
  Main field
   Non-specialist veterinarian 361 89.6 12 213 96.4
   Specialist veterinarian 42 10.4 453 3.6
   Total 403 100.0 12 666 100.0
  Main work setting
   Private practice 311 77.2 8273 81.0
   University teaching hospital 22 5.5 nd nd
   Teaching/research 21 5.2 635 6.2
   Not-for-profit veterinary practice (eg, shelter and zoo) 14 3.4 nd nd
   Government 26 6.5 488 4.8
   Industry 9 2.2 252 2.5
   Other 0 0.0 559 5.5
   Total 403 100.0 10 207 100.0
  Animal practice type
   Small companion animal (includes dogs, cats and pocket 
pets)
268 66.5 5314 64.2
   Equine 19 4.7 473 5.7
Continued
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practice as ‘significant’ whereas veterinarians and doctors 
rated these as making ‘moderate’ contributions.
Many respondents were ‘unsure’ of the contributions 
of antibiotic use in other sectors in AbR (see online 
supplementary table 4). Among valid responses, doctors 
and dentists were more likely to perceive antibiotic use 
in livestock and companion animals as ‘significant’ and 
‘moderate’, respectively, whereas veterinarians rated 
these as making ‘moderate’ and ‘minimal’ contributions 
to AbR, respectively (figure 2A).
Doctors generally rated current levels of antibiotic use 
in ‘my principal place of practice’ as making a ‘moderate’ 
contribution to AbR, whereas dentists and veterinarians 
perceived prescribing in ‘my principal place of practice’ 
as making ‘minimal’ contributions to AbR (figure 2A).
All prescriber groups rated AbR as a ‘significant’ problem 
to the health of patients in human hospitals and residents 
in nursing homes/aged care facilities (figure 2B). Veteri-
narians generally rated AbR as a ‘moderate’ problem for 
health of the livestock and food animal industry and a 
‘minor’ problem in veterinary patients, including horses, 
dogs and cats (figure 2B).
Most respondents in each prescriber group perceived 
that hospital doctors, general practitioners and 
global organisations, such as the WHO, have ‘very’ to 
‘extremely’ important roles in preventing and managing 
ABR (figure 2C). Compared with veterinarians, doctors 
and dentists were more likely to rate their own (myself) 
roles as ‘very important’ in preventing or managing 
AbR (figure 2C). However, many doctors and veterinar-
ians did not perceive their own role was as important as 
that of others in their respective prescriber groups (ie, 
hospital doctors, general practitioners and veterinarians 
in general) (figure 2C). Dentists’ ratings of their own role 
and roles of their immediate colleagues and dentists in 
general were congruent (‘very’ important).
Perceived influence of factors and barriers in prescribing 
decisions and helpfulness of interventions
All groups generally reported that patients’ clinical signs/
symptoms strongly influenced their prescribing decisions. 
A patient’s condition as critically ill or immunocompro-
mised was rated a ‘strong influence’ among all groups, 
especially doctors (figure 3A). Bacterial culture and 
susceptibility test results were rated as a ‘strong influence’ 
on doctors’ and veterinarians’ decisions to prescribe anti-
biotics or not, and as exerting ‘no influence’ or being ‘not 
applicable’ among dentists (figure 3A; online supplemen-
tary table 7). Veterinarians were more likely than doctors 
and dentists to rate immediate patient relief as an influ-
ence on prescribing decisions.
Factors rated as ‘somewhat’ of a barrier and were 
common across the professions included: lack of patient/
client understanding about antibiotics, fear of blame for 
failure to prescribe if antibiotics were later proven to 
be necessary, difficulty of making an accurate diagnosis, 
lack of clear guidelines for some conditions and fear of 
missing an infection (figure 3B). All three prescriber 
groups generally rated the following as ‘not a barrier’: 
language/culture when communicating with patients/
clients (and their carers), pressure from colleagues or 
supervisors, fear of patients/clients moving to a different 
practice and their own lack of understanding (figure 3B).
Prescriber group-specific barriers included the 
following: veterinarians were more likely than doctors and 
dentists to perceive time pressure as at least ‘somewhat’ of 
a barrier, and the cost of culture and susceptibility tests 
and the cost of some antibiotics to be at least ‘moderate’ 
barriers. Doctors and dentists generally perceived these 
costs as either lesser barriers, that is, ‘somewhat’ or ‘not 
a barrier’ (figure 3B). Veterinarians were more likely 
than doctors to perceive lack of rapid diagnostic tests as a 
‘significant’ barrier (figure 3B). Doctors were more likely 
Survey respondents National workforce
n % N %
   Livestock (includes beef, dairy, goats, sheep, pigs and poultry) 30 7.5 352 4.3
   Mixed practice 67 16.6 2134 25.8
   Other animals 11 2.7 0 0.0
   No animal handling 8 2.0 0 0.0
   Total 403 100.0 8273 100.0
*National medical workforce data from AIHW.42 In survey, ‘Hospital non-specialist’ includes interns. In national workforce statistics, ‘Hospital 
non-specialist’ excludes interns.
†National dentist workforce main field data from Dental Board of Australia.43 Main work setting data from AIHW.46
‡Number of respondents that completed a Dental Board approved specialty.
§Number of registered specialist dentists.
¶National veterinarian workforce main field data from AVBC (main field registration numbers retrieved on 18 October 2016).47 Specialist 
veterinarian registration numbers derived from State Practitioner Board annual reports and registers. Main work setting and animal practice 
type data from AVA.45
AIHW, Australian Institute of Health and Welfare; AVA, Australian Veterinary Association; AVBC, Australasian Veterinary Boards Council; GP, 
general practitioner; nd, no data available.
Table 2 Continued 
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than dentists to perceive pressures from patients as at 
least ‘somewhat’ of a barrier (figure 3B).
All prescriber groups generally perceived that better 
public awareness about AbR, timely access to antibiotic 
susceptibility patterns, access to rapid diagnostic tests, 
more education/training in prescribing, computer/
electronic aided prescribing and antimicrobial steward-
ship programmes would be ‘helpful’ or ‘very helpful’ in 
supporting more appropriate prescribing (figure 3C). 
Veterinarians generally thought that regular auditing and 
feedback on prescribing practices would be ‘somewhat 
helpful’ whereas doctors and dentists perceived these 
would be at least ‘helpful’ (figure 3C). Doctors were more 
likely than dentists and veterinarians to perceive that 
restrictions on prescribing of certain antibiotics would 
be ‘helpful’ in supporting more appropriate prescribing 
while all prescriber groups generally perceived that 
requiring all antibiotics to be authorised by a specialist or 
government authority would be ‘not helpful’ (figure 3C).
DIsCussIOn
Principal findings and comparison with other studies
The results revealed similarities and differences in knowl-
edge, attitudes and perceptions, between prescriber 
groups, about the importance, risks and causes of AbR, 
and the extent to which factors and barriers drive anti-
biotic prescribing decisions. The results also reveal a 
tendency to externalise responsibility for poor prescribing 
to ‘others’ and that there are common and context 
specific barriers to optimal prescribing.
Prescribers across all groups demonstrated high levels 
of awareness that AbR will be a greater problem in the 
future, and of its causes and extent of impact. Respon-
dents’ high levels of recognition that the transfer of resis-
tant bacteria between human, animals and environment 
has a role in the issue of AbR and that drivers and impacts 
of AbR exist in multiple contexts suggests that they have 
an awareness of AbR as a One Health issue and under-
stand the need for policies that target across human, 
animal and environmental sectors which is in line with 
the current focus of WHO activities. In addition, all 
prescriber groups concurred that a range of stakeholders 
including governments, health and medical practitioners 
and other experts, and patients/clients at the global to 
local scales across human and animal settings should have 
important roles to play in preventing and managing AbR. 
Most respondents demonstrated an understanding of 
shared responsibility through acknowledging their own 
(individual) and own profession’s responsibility for miti-
gating and managing AbR.
Results also revealed some differences between groups; 
doctors were generally more aware than dentists or veter-
inarians that a single course of antibiotics could lead to 
resistance and that resistant bacteria may persist for up 
to year in a patient after a single use of antibiotics. These 
responses likely reflect the prescribers’ context, where 
doctors more regularly encounter AbR infections and 
their immediate consequences, and strong evidence that 
AbR bacteria and long-term changes in intestinal micro-
biota can persist for a year after a single course.23 There 
is little comparable evidence about persistence of AbR 
bacteria in animals. Other interprofessional differences 
in perceptions about drivers of ABR are attributable to 
differences in their clinical practice and experience. 
For example, the finding that almost all dentists agreed 
that failure to remove the source of infection is a major 
contributor to AbR is consistent with a high proportion 
of dental infections being accessible to drainage or tooth 
removal.24 Veterinarians probably were more aware of the 
risk of ABR induced by subtherapeutic antibiotic doses, 
because of widespread concern about their use as growth 
promoters, based on evidence that exposure of bacteria 
to low antibiotic concentrations in vitro promotes muta-
genesis and horizontal gene transfer.25 Veterinarians were 
less concerned, than others, about the effect on ABR, of 
broad-spectrum antibiotics or unnecessarily long courses, 
perhaps because guidelines about choice and duration of 
therapy, for different conditions in animals are less avail-
able than for human use.9 Doctors were less concerned 
about patients not finishing a full course of antibiotic, 
which is consistent with recent discussion in the medical 
literature about lack of evidence that it contributes to 
ABR.26 27
While most doctors and veterinarians agreed that anti-
biotic prescribing by their professions contributed signifi-
cantly to the issue of AbR, they were less likely to believe 
prescribing in their own (individual) practice contributes 
to the same extent. Many doctors and dentists, in common 
with human health practitioners in previous studies, 
saw antibiotic use in livestock as a significant driver of 
AbR in humans.21 28 On the other hand, consistent with 
some existing studies, many veterinarians did not.29 This 
tension may reflect the limited evidence of, uncertainty 
about, and geographical variation in contributions of 
agricultural antibiotic use and environmental contamina-
tion to AbR in humans.25 30 Since most veterinary respon-
dents were small animal veterinarians, they likely do not 
consider their work as contributing to resistance within 
the food chain.31 Attribution of blame or externalisation of 
responsibility to others is a major barrier to behavioural 
change and must be understood, accounted for, and 
managed in developing policies.32 Enabling behavioural 
change will require that prescribers perceive their own 
personal roles and actions as efficacious and important 
in relation to AbR.33 Our results reveal a strong acknowl-
edgement particularly among doctors of their role in 
helping to manage AbR.
Lack of patient/client understanding of antibiotics, 
difficulty making an accurate diagnosis and fear of missing 
an infection or being blamed for poor outcomes were 
generally rated as barriers to appropriate prescribing, 
at least to some extent, across all groups. From a poli-
cy-making perspective, it is important to recognise these 
common barriers because they indicate broader chal-
lenges across individual professions or settings, such as 
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the need for greater public awareness of AbR and a need 
to reduce diagnostic uncertainty by developing faster and 
more accessible diagnostic tests to limit the need for risk 
averse strategies of prescribing unnecessarily or ‘just in 
case’.34 Sharing of resources, experience, approaches or 
knowledge across disciplines should help to identify and 
effect possible solutions. Consistent with the increasing 
demand for integrated antimicrobial use and AbR surveil-
lance across human and animal health,35 our results 
suggest that changes in prescribing behaviour could 
be facilitated through exchanging information across 
different prescriber groups.
At the same time, specific efforts will need to address 
profession-specific issues, ensuring efficient resource 
allocation.36 For example, structural and commercial 
pressures were greater for veterinarians than dentists and 
doctors in the sample, highlighting the potential need for 
targeted approaches. While solutions exist for doctors and 
dentists that reduce these barriers, for example, bacte-
rial culture and susceptibility tests in Australia are often 
publicly subsidised for human patients, there is no such 
subsidy in the veterinary sector. Comparisons across these 
prescriber groups reveal important gaps and disparities 
in resources, levels of knowledge and abilities to commit 
to best practice. These gaps indicate where there might 
be room for sharing of resources, such as diagnostic tools 
and knowledge, policy mechanisms and approaches, 
across sectors.
Contrary to the existing literature, respondents did not 
consider commonly reported barriers, such as patient/
client pressure and expectations as having a ‘significant’ 
influence on prescribing, despite indicating that better 
public awareness of the issue would be ‘very helpful’.37 
This reveals an inconsistency between respondents 
perceived and actual experiences. On the one hand, 
prescribers recognised that they play a role in worsening 
the problem and did not generally perceive any major 
barriers to optimal prescribing. On the other, there is 
substantial evidence of suboptimal antibiotic prescribing 
in humans and animals.35 38 These observations might 
reflect a limitation of surveys in asking about sensitive 
topics or undesirable behaviours, but warrant a more 
sophisticated understanding of the drivers of prescribing 
behaviour that might be operating.
Prescribers might support interventions that encourage 
optimal prescribing, including regular auditing and 
personal feedback. However, they generally perceived 
more restrictive interventions as ‘not helpful’. This 
implies that the perception of infringement on personal 
decision-making and professional autonomy is a poten-
tial barrier to more restrictive policy-making.39 Such views 
are at odds with a global movement towards formal AbR 
stewardship programmes and increasingly restrictive poli-
cies.40 Nevertheless, experience with hospital antimicro-
bial stewardship programmes in human health suggests 
that prescribers are responsive to audit, feedback and 
benchmarking strategies, which support improved 
prescribing despite diagnostic uncertainties, whereas they 
are less supportive of outright restrictions. This represents 
a challenge for policy-making and implementation, which 
will need to take account of the behaviours of prescribers, 
their roles as front-line decision-makers, and how they 
see their rights and responsibilities as experts. Efforts 
will need to ensure any proposed guidelines, regulations, 
regular audit cycles and reviews of prescribing practice 
are not seen as punitive. Policy-makers could look to regu-
latory approaches in cognate health areas such as tuber-
culosis and HIV chemotherapies for working examples.
strengths and limitations of study
The key strength of the study lies in the simultaneous 
surveying of doctors, dentists and veterinarians allowing 
for direct comparisons between knowledge, attitudes and 
perceptions to reveal the gaps, opportunities and chal-
lenges for a One Health approach towards appropriate 
use of antibiotics. To our knowledge, this is a global first.
Certain prescribers were over-represented and others 
under-represented in terms of the states and territories 
and main fields in which they practised, and therefore our 
sample was not completely representative of each profes-
sion. As the sample was self-selecting, it may have led to 
selection bias of those who were already interested in the 
topic of AbR and/or those held stronger views. A conse-
quence of asking sensitive questions about prescribing 
behaviour may have led to reporting of responses they 
thought were ‘appropriate’ or socially desirable, especially 
in relation to factors that influenced their prescribing 
decisions, rather than representing their actual views or 
experiences. The questionnaire asked participants to 
reflect in a straightforward manner and to provide general 
answers about knowledge, attitudes and behaviours, but 
these dimensions are in reality, situated in and dependent 
on contexts. A limitation of self-reporting on factors and 
barriers as influencing prescribing decisions is that this 
depends on the levels of awareness and salience of these 
drivers, which may differ between respondents. Further 
qualitative research should be undertaken to determine 
how factors and barriers operate and whether prescribers 
see any other facets as operating as barriers to optimal 
prescribing in their practice. Nevertheless, this study 
provides a baseline from which to broadly compare expe-
riences and identifies the needs of a key subset of Austra-
lian human and animal health professionals.
Conclusions and implications for One health policy-making
A coordinated One Health response to improving anti-
biotic use and reducing AbR requires shared aware-
ness, support and commitment, of all stakeholders. The 
majority of respondents across all prescriber groups were 
aware of the current and increasing problem of AbR, 
which is an encouraging foundation towards achieving a 
One Health approach. However, characterisations of AbR 
more as a human health problem than an animal health 
problem and externalisation of responsibility of AbR on 
to others (by all prescriber groups) represent a challenge 
to achieving a One Health approach, as individuals may 
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be less critical of their own actions in relation to others. 
We suggest that policy-makers and practitioners should 
look to successes of interventions that have increased 
doctors’ awareness of personal responsibility and adapt 
and trial these approaches when designing similar inter-
ventions for dentists and veterinarians.41 Comparisons 
across groups revealed that different prescribers have 
specific knowledge gaps and practical uncertainties and 
are influenced by different sets of factors and barriers 
when prescribing antibiotics, suggesting that poli-
cy-making which includes strategies to improve antibiotic 
use should be sensitive and tailored to these experiences. 
Prescribers also have different preferences for and expe-
riences with strategies aimed at supporting appropriate 
prescribing. However, some barriers and perceptions of 
strategies are similar across prescribers which suggests 
that there are opportunities towards achieving a One 
Health approach to improving antibiotic prescribing 
and addressing gaps through sharing knowledge and 
resources across settings and fields. Additionally, design 
of more restrictive policies should consider the perceived 
impacts on prescriber autonomy within the bounds of 
optimal prescribing practice. Although this study focused 
on prescribers in Australia, we believe that the results are 
of global relevance.
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